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Abstract:  Due to increased activity in high-throughput structural genomics efforts around the globe, 
there has been a steady accumulation of experimentally solved protein 3D structures lacking functional 
annotation, thus creating a need for structure-based protein function assignment methods. 
Computational prediction of ligand binding sites (LBS) is a well-established protein function 
assignment method.  Here we apply the specific ligand binding site detection algorithm we recently 
described (Reyes, V.M. & Sheth, V.N., 2011; Reyes, V.M., 2015a) to some 801 functionally 
unannotated experimental structures in the Protein Data Bank by screening for the binding sites of six 
biologically important ligands, namely: GTP in small Ras-type G-proteins, ATP in ser/thr protein 
kinases, sialic acid, retinoic acid, and heme-bound and unbound (free) nitric oxide. Validation of the 
algorithm for the GTP- and ATP-binding sites has been previously described in detail (ibid.); here, 
validation for the binding sites of the four other ligands shows both good specificity and sensitivity. Of 
the 801 structures screened, eight tested positive for GTP binding, 61 for ATP binding, 35 for sialic 
acid binding, 132 for retinoic acid binding, 33 for heme-bound nitric oxide binding, and 10 for free 
nitric oxide binding. Using the ‘cutting plane’ and ‘tangent sphere’ methods we described previously, 
(Reyes, V.M., 2015b), we also determined the depth of burial of the ligand binding sites detected above 
and compared the values with those from the respective training structures, and the degree of similarity 
between the two values taken as a further validation of the predicted LBSs.  Applying this criterion, we 
were able to narrow down the predicted GTP-binding proteins to two, the ATP-binding proteins to 13, 
the sialic acid-binding proteins to two, the retinoic acid-binding proteins to 14, the heme-bound NO-
binding proteins to four, and the unbound NO-binding proteins to one. We believe this further criterion 
increases the confidence level of our LBS predictions. The next logical step would be the experimental 
determination of the actual binding of these putative proteins to their respective ligands.  
 
 
Keywords: GTP binding site/proteins, ATP binding site/proteins, sialic acid binding 
site/proteins, retinoic acid binding site/proteins, heme-NO binding site/proteins, unbound NO 
binding site/prote4ins, protein function prediction, protein function annotation, protein-ligand 
interaction(s) 
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Abbreviations:   BS, binding site; LBS, ligand binding site; PDB, Protein Data Bank; GTP, guanosine 
triphosphate; ATP, adenosine triphosphate; SRGP, small Ras-type G-proteins; STPK, ser/thr protein 
kinase; SIA, sialic acid; REA, retinoic acid; NO, nitric oxide; hNO, heme-bound NO;  fNO, free or 
unbound NO; PLI, protein ligand interaction(s); 3D SM, 3-dimensional search motif; CP, cutting plane; 
CPM, CP method; TS, tangent sphere; TSM, TS method; CPi, cutting plane index; TSi, tangent sphere 
index; H-bond, hydrogen bond; VDW, van der Waals; AAR, all-atom representation; DCRR, double-
centroid reduced representation; Z(s), the side-chain centroid of amino acid Z; X(b), the backbone 
centroid of amino acid X; DCRR, double-centroid reduced representation 
1   Introduction. 
Progress in both the genomic sequencing efforts around the globe (Burley, S.K.  2000; Heinemann, U.  
2000; Terwilliger, T.C., 2000; Norrvell, J.C., & Machalek, A.Z., 2000) as well as that of the various 
high-throughput 3D structure-determination methods (experimental or predicted) of proteins have 
brought about the accumulation of protein structures which completely lack functional information 
(Bentley et al., 2004; Murphy et al, 2004; Baxevanis, 2003; Miller et al,, 2003).  For instance, the 
Protein Data Bank (PDB), the world’s repository for protein 3D structures, has recently witnessed an 
accumulation of experimentally determined protein 3D structures whose functions are unknown 
(Berman, H.M., & Westbrook, J.D.  2004). This, in turn, has created the need for computational 
methods of structure-based protein function prediction, especially those which can be implemented 
automatically in high-throughput fashion (Jung, J.W. & Lee, W.  2004; Yakunin, A.F., et al., 2004 ).  
One of the main roles of bioinformatics (or computational biology) in this post-genomic era of biology 
is to reduce the workload of the experimentalists by computationally “eliminating” candidates for 
experimentation, thereby allowing them to invest their time and effort on the “good” ones that are more 
likely to yield useful results.  This is one of the main objectives of the present work.     
 
There are a number of established ways to predict (computationally) the function of a protein whose 
3D structure (and amino acid sequence) is known.  One way to do this is to predict the ligand(s) that 
the protein binds. To do this based on the 3D structure of the protein, one can proceed by detecting the 
ligand's binding site - the ligand’s specific ‘signature’ on its receptor protein - in the receptor protein’s 
3D structure. Ligands usually dock on the surface of a protein, and a ligand’s binding site (BS, LBS) is 
“buried” within the receptor protein’s interior to varying degrees.  
 
The work we describe here involves the prediction of the binding sites of six biologically important 
ligands, namely: GTP, ATP, sialic acid, retinoic acid and nitric oxide in heme-bound and unbound 
forms. The biological roles of GTP and ATP are widely established (for example, see Mazzorana M, et 
al., 2008, and Stork PJ., 2003, respectively) Since both GTP- and ATP-binding proteins are highly 
heterogeneous, we focus here on the small Ras-type G-proteins (SRGP) and the ser/thr protein kinase 
(STPK) families, respectively. Sialic acid (SIA) is a C9 monosaccharide, and is the key component of 
mucus that allows the latter to prevent infections; more importantly, however, it has a significant role 
in the regulation of cellular communication (Lehmann et al., 2006; Miyagi et al., 2004).  Retinoic acid 
(REA), on the other hand, has important roles in the transcriptional modulation of certain target genes 
by interacting with any one of its three known receptors: alpha, beta and gamma (Germain et al., 2006; 
Wolf, 2006).  Finally, nitric oxide (NO) is an important signaling molecule in various cell types (Cary 
et al., 2006; Brunori et al., 2006; Perreti et al., 2006; Russwurm et al., 2004) which may either be in 
heme-bound (hNO) or unbound (fNO) forms. 
 
The binding sites of these ligands were first characterized from ligand-containing experimentally 
solved structures from the PDB. These collection of structures from which the binding mode of the 
ligands are “learned” by an algorithm is called the ‘training set’ for the specific ligand in question.  The 
salient features of the binding sites are then encoded in a tetrahedral tree data structure we designate as 
the ‘3D search motif’ (3D SM).   Using a novel analytical screening algorithm we developed earlier 
(Reyes, V.M., & Sheth, V.N., 2011; Reyes, V.M., 2015a), a set of some 801 experimentally solved but 
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functionally unannotated protein structures from the PDB were screened for these 3D search 
motifs.  Of the 801, we detected 8 putative SRGP GTP-binding proteins, 61 putative STPK ATP-
binding proteins, 35 putative SIA-binding proteins, 132 putative REA-binding proteins, 33 putative 
hNO-binding proteins, and 10 putative fNO-binding proteins.  These candidate proteins were then 
subjected to the “cutting plane” and “tangent sphere” methods (Reyes, V.M., 2015b) as a further 
validation step. This method is a way to assess the degree of burial of a local functional site such as a 
ligand-binding site in a protein The validation depends on the putative structure having the same or 
similar depth of ligand binding site burial as those in the training structures.  To our knowledge, this 
work is the first computational investigation that predicts the binding sites for GTP, ATP, SIA, REA, 
hNO and fNO from among functionally unannotated structures in the PDB, and further screens those 
proteins using information regarding the depth of burial of the bound ligand within its cognate receptor 
protein.     
2   Datasets and Methods. 
2.1   The Training Structures.  
The screening method used here has been reported previously by us (Reyes, V.M., & Sheth, V.N., 
2011; Reyes, V.M., 2015a). It requires the construction of a ‘3D search motif’ (3D SM) from a set of 
training structures, and is based on the geometry and architecture of the ligand binding site (LBS) in 
question.  The 3D SM is essentially a ‘signature’ of the LBS in question and contains at least six 
quantitative and eight qualitative parameters which are all inputted into the algorithm to enable it to 
detect the said LBS.  The training structures for ATP-binding STPK proteins and GTP-binding SRGP 
proteins have been described and discussed in detail previously (ibid.).  The training structures used for 
the construction of the 3D SM for the SIA are 1JSN, 1JSO, 1W0O, 1W0P, 1MQN (chains A and D); 
the training structures used to construct the 3D SM for REA are 1FM9, 1K74, 1FBY (chains A and B), 
1FM6 (chains A and U), 1XDK (chains A and E), 1XLS (chains A, B, C and D), 2ACL (chains G, A, 
C and E); the training structures used for the construction of the 3D SM for hNO are 1OZW, 1XK3, 
1ZOL (chains A and B); and finally, the training structures used to construct the 3D SM for fNO is 
1ZGN, chains A and B.  These training structures are all described in Table 1.  The set of 801 protein 
structures in the PDB (all experimentally solved, mostly by x-ray crystallography) that lacked 
functional annotation at the time of this work are shown in Table 2. These proteins of unknown 
function come from many different species, but most are from E. coli,  T. maritima, T. thermophilus, B. 
subtilis, P. aeruginosa, H. influenzae and A. fulgidus; only 18 (2.25%) come from H. sapiens. We used 
this set as the ‘application set’ – the set of 3D structures that we screened for the LBS’s in question for 
the purpose of assigning function to.   In addition to determining the 3D SM from the above training 
structures, we also determined the depth of ligand burial in each, since this information is required in 
the next stages of our overall screening protocol.       
2.2   Methods 
2.2.1    Determination of the 3D SM’s.     
 
The overall methodology followed in this work has been described in detail (Reyes, V.M., & Sheth, 
V.N., 2011; Reyes, V.M., 2015a).   Briefly, the set of all hydrogen bonding (H-bonding) and van der 
Waals (VDW) interactions between ligand and protein in the training structures are sequestered (Engh, 
R.A. & Huber, R., 1991); Bondi, A., 1964).  Then the most dominant and/or recurrent interactions 
among the training structures are determined, and designated the ‘3D binding consensus motif’.  From 
such a consensus interaction mode between ligand and protein, the corresponding 3D SM is 
constructed. The 3D SM is a tetrahedral collection of four points in space representing the protein 
residues most commonly in association with the ligand (in the training structures).  In the 3D SM, the 
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protein is in a reduced representation which we call the “double centroid reduced representation” 
(DCRR), where each amino acid is represented by two points, namely: the centroid of its backbone 
atoms (N, CA, C’, O), and that of its side chain atoms (CB, CG, etc.).  The application set is then 
screened for the tetrahedral 3D SM using a screening algorithm we developed earlier (ibid.).  The 
tetrahedral 3D SM’s for the six ligands in this study are shown in Figure 1, Panels A-D.  The 
tetrahedral 3D SM is not just a collection of four points in space; it is a data structure that embodies a 
relatively large amount information about the binding site of the ligand in question.  Specifically, it 
contains at least eight qualitative parameters, namely: the identities of the four amino acids in the 
tetrahedron (may be more if similar amino acids can interact with any of the ligand atoms in other 
receptor proteins) and their mode of association with the ligand (whether with backbone or side chain; 
hence, 4 x 2 = 8) and exactly six quantitative parameters (the lengths of the six sides of the tetrahedron) 
about the ligand binding site in question. Hence the 3D SM contains a total of 8 + 6 = 14 combined 
qualitative and quantitative parameters. This property makes the algorithm optimally specific for the 
ligand in question (ibid.).    
 
2.2.2    Determining the Degree of Burial of the Ligand Binding Sites.     
 
In our screening protocol, there are two further steps after the detection of the LBS’s using the 3D SM 
method (although this step is the most crucial).  These two last steps depend on the “cutting plane” and 
“tangent sphere” methods (CPM and TSM, respectively) of ligand burial depth quantitative 
determination methods we reported previously (Reyes,.V.M., 2015b; see also Figure 2).  These two 
methods are complementary and produce numerical measures which we term the “CP index” (CPi) and 
“TS index” (TSi), respectively, and which are essentially quantitative measures of the degrees of burial 
of a given ligand or LBS. These two additional steps are meant to narrow down the set of structures 
testing positive for the presence of a particular LBS and thus serve to further validate the prediction 
results. Specifically, those which have LBS burial depths resembling those in the training structures are 
deemed more likely to be true positives than those whose degrees of LBS burial are quite different.    
3  Results 
The determination of the 3D SM and the validation stage (testing positive and negative control 
structures) for the GTP-binding site in SRGPs and the ATP-binding site in STPKs have both been 
presented and discussed in detail in our previous work (Reyes, V.M., 2015a), so we shall not touch 
upon them here and just limit our discussion in the following sections to SIA, REA, hNO and fNO 
binding sites. 
3.1   Determination of the 3D SM for Sialic Acid (SIA) Binding Sites. 
 The H-bonds between SIA and its receptor protein in the training structures are dominated by 
interactions between atom N5 of SIA and the backbone O of a Gly or a Val residue in the BS; atom 
O1A of SIA and either an NH1 atom of an Arg or an OE1 or NE2 atom of a Gln residue in the BS; and 
atom O8 of SIA and the hydroxyl O of a Ser or a Tyr residue in the BS.  The VDW interactions, on the 
other hand, are mainly between atom C7 of SIA and either the CH2 side chain atom of a Trp or the CE 
side chain atom of a Met residue in the BS.  Careful consideration of these interactions enabled us to 
build the 3D search motif for SIA shown in Figure 1A. 
3.2   Determination of the 3D SM for Retinoic Acid (REA) Binding Sites. 
The H-bonds between REA and its receptor protein in the training structures are dominated by 
interactions between atom O1 of REA and the terminal side chain amino group of an Arg residue, and 
atom O2 of REA and the backbone N of an Ala residue in the BS.  The VDW interactions, on the other 
hand, are mainly between atom C3 of REA and one of the side chain carbon atoms of an Ile or a Val 
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residue in the BS; atom C17 of REA and either atom CB of a His or a Cys residue, or the backbone 
O of a Cys residue in the BS; and finally atom C20 of REA and the CD2 atom of a Phe or a Leu 
residue in the BS.  Careful consideration of these interactions led us to construct the 3D SM for REA 
shown in Figure 1B.  
3.3   Determination of the 3D SM for Heme-Bound Nitric Oxide (hNO) Binding Sites. 
The H-bonds between hNO and its receptor protein in the training structures are dominated by 
interactions between the heme iron and the side chain amino group of a His residue in the BS; the O2D 
atom of heme and a side chain amino group of an Arg residue in the BS; and atom O of NO and a Gly 
residue atom or a side chain C atom of a Leu residue in the BS.  The VDW interactions, on the other 
hand, are mainly between atom CHD of heme and a side chain C atom of a Phe or a Gly residue in the 
BS; and between atom O2D of heme and a side chain atom of a His or a Tyr residue in the BS. Careful 
consideration of the above interactions allowed us to build the 3D SM for hNO shown in Figure 1C. 
3.4   Determination of the 3D SM for Free/Unbound Nitric Oxide (fNO) Binding Sites. 
The H-bonds between fNO and its receptor protein in the single training structure (with two protein 
chains) involve N atom of fNO and the backbone N of an Arg residue or the side chain OH group of a 
Tyr residue in the BS. The VDW interactions, on the other hand, are mainly between the N atom of 
fNO and an atom of a Gly or a Val residue in the BS, or between atom O of fNO and a side chain C 
atom of an Ile or Phe residue in the BS.  Careful consideration of these interactions allowed us to the 
construct the 3D SM for unbound fNO shown in Figure 1D. 
3.5   Validation Step:  Positive and Negative Controls  
3.5.1.   Negative Control Structures. 
 
Thirty negative control structures were used for the validation of the BS’s for all six protein families 
studied here; they are, namely: 135L, 1A1M, 1A6T, 1BHC, 1PSN, 1BRF,   1EWK, 1CBN, 1MV5, 
1JFF, 104M, 1ASH, 1B3B, 1BRF, 1CKO, 1CRP, 1EWK, 1F3O, 1FW5, 1HWY, 1JBP, 1MJJ, 1MV5,   
1NQT, 1OGU, 1PE6, 1RDQ, 1SVS, 1TWY and 1Z3C.  The above structures are all described in Table 
3.  Our results show that in all cases, the algorithm found no 3D SM in any of the negative control 
structures as expected. These results imply that the algorithm is highly specific for their respective 
ligands.   
 
3.5.2.   Positive Control Structures. 
  
As for positive control structures, we note that there are no other appropriate positive structures in the 
PDB for the four above ligands as all of them have been used as training structures. Positive control 
structures to be used for validation must be yet “unseen” by the algorithm. We thus constructed 
artificial positive control structures from the negative control structures by replacing four appropriate 
amino acid residues in the latter to make a legitimate 3D SM for the particular ligand. These artificially 
mutated structures were then screened for the appropriate 3D SM using our algorithm.  In all cases, the 
algorithm detected the artificially embedded 3D SM for the particular ligand (data not shown).  These 
results imply that the screening algorithm has high sensitivity for the 3D SM corresponding to the 
particular ligand.      
3.6   Screening Results  
The screening process is illustrated in Figure 2. There are three stages in our screening process, the first 
stage and the most important being the LBS determination.  The next stages involve the determination 
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of the LBS burial in the putative structures from the preceding stage.  This is done by determining 
their CPi and TSi, respectively.  The computed values are compared against the CPi and TSi of the 
respective training structures, and those putative structures having CPi and TSi closest to any of those 
of the training structures are deemed “double positives”, and are thus are considered best ligand-
binding candidates in their respective protein families (see below). The application set, the 801 
functionally unannotated structures in the PDB that served as application structures for this study, is 
shown in Table 2.  These proteins come from a diverse distribution of species (see Table 4).  The 
‘Cutting Plane’ and ‘Tangent Sphere’ methods, on the other hand, are illustrated in Figure 1, Panels A 
and B, of our previous paper (Reyes, V.M., 2015b), which schematically illustrate the two methods and 
how they complement each other.  
 
Overall results are as follows: of the 801 application structures, we detected 61 putative ATP-binding 
STPK proteins (7.6%), eight GTP-binding SRGP proteins (1.0%), 35 putative SIA-binding proteins 
(4.4%), 132 putative REA-binding proteins (16.5%), 33 putative hNO binding proteins (4.1%), and 10 
fNO binding proteins (1.2%).   We now show the details of these screening results in the following 
sections.  Note that a protein that tested positive for a particular LBS may have more than one chain, 
and one or more LBSs may have been detected in each chain.   
 
In the first 6 subtables of Table 5, the blue entries on top are the training structures for the particular 3D 
SM.  Meanwhile, the black entries below are the structures that tested positive for the ligand in 
question.  The headings “CPM” and “TSM” stand for “cutting plane” and “tangent sphere” methods, 
respectively.   The red arrows point out those positive structures whose CPM and TSM indices are 
either within an arbitrarily set  difference, e.g., within 8-10%,  from any one of those of the training 
structures, respectively, of the closest one in the set.  In each case, integration of these ligand burial 
depth results with those of the LBS screening results further trim down the positive set, at the same 
time further validating the LBS existence prediction. The information contained in the different parts of 
the tables are illustrated and explained diagrammatically in part 7 (of 7) of Table 5.  Note that due to 
the large number of structures testing positive for the LBS (first stage of screening) in question in the 
two cases of ATP-binding STPK and REA-binding protein families (Table 5, part 2 of 7 and part 4 of 
7, respectively) this diagram is not strictly adhered to. Instead, only structures with CPi and TSi values 
within 10.0 Å of those of a training structure are shown. 
                        
3.6.1   Screening Results for GTP-Binding Sites in Small Ras-type G-Proteins.   Eight structures 
(1.0% of the original 801) tested positive in the initial screening step, the detection of the 3D SM for 
GTP (Table 5, part 1 of 7).  This set then got reduced to seven (0.9%) after matching their CPi or TSi 
(i.e., at least one of them) values to those of the training structures.  From these seven structures, two 
(0.2%) stand out, namely, 1XT1 and 1RU8, because both of their CPi and TSi values are close to those 
of one of the structures in the training set (see Table 6).      
 
3.6.2   Screening Results for ATP-Binding Sites in ser/thr Proein Kinases.  The number of 
structures that tested positive for the ATP BS for this family is 61 (7.6%; see Table 5, part 2 of 7).  By 
incorporating the ligand burial depth data from the CP and TS methods, 24 of the 61 structures testing 
positive for the ATP-binding site have been eliminated, leaving 37 structures (4.6%). Out of these 37, 
the following 11 to 13 structures (ca. 1.6%) are strong candidates because their CPi’s and TSi’s 
resemble both those of a training structure:  1WM6, 2CV1, 1RKQ, 1NF2, 1TQ6, 1MWW, 1TT7, 1T57, 
1F19, 1RKI, 1Y9E (and possibly 1VPH and 1YYV as well; see Schwarzenbacher R. et al., 2004; 
Teplyakov A. et al., 2002; Beeby M. et al., 2005; Kunishima N. et al., 2005; see also Table 6).    
 
3.6.3   Screening Results for Sialic Acid Binding Sites.   For this ligand, 35 (4.4%) structures tested 
positive for the SIA binding site (Table 5, part 3 of 7).  Of these, only 20 (2.5%) possess either a CPi or 
TSi close to that of a training structure.  Of these 20, two structures (0.2%) namely, 1VKA and 1IUK, 
stand out as both of their CPi and TSi values resemble both the CPi and TSi values of one of the 
structures in the training set for this ligand (see Table 6).        
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3.6.4   Screening Results for Retinoic Acid Binding Sites.  Of the 801 application structures, 132 
(16.5%) tested positive for the REA binding site.  Incorporating the ligand burial depth data from the 
CPM and TSM methods, almost 60% of the above 132 structures have been eliminated, leaving 53 
candidate structures (6.6%; Table 5, part 4 of 7). The following 13 or 14 structures (ca. 1.7%) are 
strong candidates because both their CPi’s and TSi’s resemble both those of a training structure:   
1YEY, 1NX4, 1TU1, 1Y8T, 2EVR, 1WU8, 1R1H, 1U61, 1T6S, 1NX8, 1NJH, 1Z6M, and 1VIM (and 
possibly 1ZE0 as well; see Clifton, I.J. et al., 2003; Asch WS, Schechter N., 2000; see also Table 6).   
 
3.6.5   Screening for Heme-Bound NO Binding Sites.  For this ligand, 33 structures (4.1%) tested 
positive for the hNO binding site. They have been further trimmed down to 12 (1.5%) upon 
incorporation of the ligand burial data using the CPM and TSM (Table 5, part 5 of 7).   Of these 12, 
four structures (0.5%), namely  1ZSW, 1VKH, 1UAN and 2B4W stand out as their CPi and TSi values 
resemble both those from a training structure for this ligand (see Arndt, J.W. et al. 2005; Zhou C.Z. et 
al., 2005; see also Table 6). 
 
3.6.6   Screening for Free/Unbound NO Binding Sites.    In this set, the 10 structures (1.2%) tested 
positive for the fNO binding site.  These have been narrowed down to six (0.7%) upon including the 
results from the CPM and TSM ligand burial data (Table 5, part 6 of 7).  Of these six, a single structure 
(0.1%), namely, 1UC2, stands out as its CPi and TSi values both resemble those by the lone training 
structure, 1ZGN., for this ligand (see Table 6). 
4   Discussion.  
Using a novel analytical screening algorithm we developed earlier (Reyes, V.M., & Sheth, V.N., 2011; 
Reyes, V.M., 2015a), we have screened some 801 functionally unannotated x-ray diffraction structures 
deposited in the PDB for the binding sites of GTP, ATP, sialic acid, retinoic acid, and heme-bound and 
unbound nitric oxide.  We detected eight SRGP GTP-binding sites, 61 STPK ATP-binding sites, 35 
SIA-binding sites, 132 REA-binding sites, 33 hNO-binding sites and 10 fNO binding sites, with some 
structures containing more than one binding site for the ligand in question.   The detection of the LBS 
for a particular ligand was accomplished by detecting the 3D SM for that ligand in the protein 
structures.  This idea depends on the assumption that the 3D SM (and hence the binding site 
characteristics) for a given ligand is conserved within a protein family.     
 
Using another novel analytical method we developed earlier (Reyes, V.M., 2015b) called the “cutting 
plane” and “tangent sphere” methods, the degrees of burial of these ligand binding sites were also 
determined and used as a further validation step for the ligand binding prediction.  Thus the positive 
structures above were further culled by comparing their CPi or TSi to those of the training structures 
for the protein family and those which had similar values were retained, the rationale being those which 
have depths of LBS burial resembling those in the training structures are deemed more likely to be true 
positives than those who do not. This criterion depends on the reasonable premise that ligand burial 
depth is characteristic of a particular ligand-binding protein family.   
 
Our LBS detection method depends on the availability of protein complex 3D structures with the bound 
ligand under study and as such relies heavily on the contents of the PDB. Although experimental 
structures for GTP- and ATP-binding proteins abound in the PDB, structures of proteins bound with 
other ligands are underrepresented. For example, the scarcity of structures containing SIA, REA, hNO 
and fNO in the PDB is a limitation in terms of having an ample number of both training and control 
(validation) sets for our screening algorithm.  However, since our screening algorithm is largely 
analytical, the need for exhaustive positive and negative control structures is not that critical compared 
to statistical algorithms such as those based on SVM and neural networks.  This is one advantage of an 
analytical algorithm over a stochastic one. 
 
The fuzzy factor or margin, ε, we incorporate into the branches and node-edges in the 3D SM are 
usually in the order of 1.0 - 1.5 Å (Reyes, V.M. & Sheth, V.N., 2011; Reyes, V.M., 2015a).  Thus in 
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cases where the protein assumes drastic conformational changes upon ligand binding and 
displacements of amino acid residues at the binding site are much greater than 1.5 Å, our method will 
perhaps likely fail.  We believe it is reasonable to assume that the deeper within the protein interior the 
LBS lies, the more drastic the conformational changes the protein undergoes upon binding the ligand 
(i.e., in transitioning from the ‘apo’ to the complexed form).  But whether or not the predictive power 
of our algorithm decreases as the LBS lies deeper within the protein remains to be investigated. 
 
In the determination of H-bonds between protein and ligand to build the 3D SM, we did not ascertain 
the linearity of the bonds of the interacting atoms between ligand and protein (amino acids in the BS); 
we merely measured non-hydrogen interatomic distances and we sequester only those with perfect or 
near-perfect H-bond distances (2.7Å-2.9 Å). Thus this issue is unlikely to have a significant adverse 
effect on our results, as instances in which the H-bonding atoms have perfect or near-prefect H-
bonding distances and at the same time non-linear, are quite rare.   
5   Summary and Conclusions. 
By determining the most prevalent and/or dominant H-bonding and VDW interactions between ligand 
atoms and amino acid residue atoms in the BS of its receptor protein, we have constructed a 'signature' 
of the binding sites of six biologically important ligands – GTP,  ATP, SIA, REA, hNO and fNO. We 
designate this ‘signature’ as the 3D BS consensus motif for the particular ligand.  We have then 
encoded these binding site signatures in a tetrahedral tree data structure we call the 3D search motif or 
“3D SM” for the ligand in question. Then, using a novel analytical search algorithm we developed 
earlier (Reyes, V.M., & Sheth, V.N., 2011; Reyes, V.M., 2015a) experimentally determined protein 
structures in the PDB that lacked functional annotation were screened for the above five ligands. We 
detected eight structures with the GTP-binding site of the SRGP family, 61 structures with the ATP-
binding site of the STPK family, 35 structures with the SIA binding site signature, 132 with the REA's, 
33 with the heme-bound NO's, and 10 with the free NO's.  The positive proteins above were further 
subjected to validation by determining the depth of burial of their LBS’s using their CPi and TSi values 
and comparing them to those of their training structures. Respectively seven, 37, 20, 53, 12, and six of 
the GTP-, ATP-, SIA-, REA-, hNO- and fNO-binding proteins had either their CPi or TSi close to 
those of a retaining structure for the protein family.  Of these, respectively two, 28 (of which 13 stand 
out from the rest), two,  30 (of which 14 stand out from the rest), four and one of the GTP-, ATP-, SIA-
, REA-, hNO- and fNO-binding proteins had both of their CPi and TSi close to those of a retaining 
structure for the protein family.  Thus by incorporating information about the depth of LBS burial in 
the positive proteins from the 3D SM screening, they can be further narrowed down significantly for  
increased confidence in the LBS prediction. At this point in the protein function prediction process, the 
job of the bioinformaticist is usually done and the experimentalists take over. Thus we are currently 
awaiting experimental verification of the results we report here. Our final results are shown in Table 6.  
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FIGURE LEGENDS:   
 
Figure 1, Panels A-D:    The 3D Search Motifs.   The 3D search motifs for the four ligands under 
study are shown:  Panels A-D: Sialic acid, retinoic acid, heme-bound nitric oxide, and unbound nitric 
oxide search motifs, respectively.  The lengths of the six sides of the tetrahedral motif (in Å) are also 
shown in an accompanying side table; the numbers inside parentheses are the corresponding standard 
deviations from the training structures.  The ligand in each case is shown with its component atom 
names.  The amino acids representing the tetrahedral vertices are indicated, with “(s)” indicating side 
chain interaction with ligand, and “(b)”, backbone interaction.   The root and three nodes are also 
indicated by the boxed letters. 
 
Figure 2.   The Elimination Process.  Both local and global structure information are utilized in the 
process of elimination to search for candidate positive structures.  Set A, the outermost red circle, 
represents the starting test/application set composed of 801 PDB structures without functional 
annotation.  They are first screened for the particular 3D SM in question, and those that test positive, 
i.e., those that possess the 3D SM, form a subset of A; we call it set B (blue circle). Set B structures are 
then subjected to the “Cutting Plane” and “Tangent sphere” Methods (Reyes, V.M., 2015b).  The CPM 
and TSM indices (CPMi and TSMi, respectively) of each structure are then compared respectively to 
those of t he training structures used to create the 3D SM’s.  Those whose CPMi or TSMi are within 
several units (typically 8-10) of those of the training structures, are considered to have similar indices, 
and form a subset of B; we call it set C (brown circle).  Structures in set C are further analyzed to 
determine whether their indices are both respectively similar to those any one or more of the training 
structures. Those which satisfy this criterion form a subset of C, which we call set D (green circle).  
This main advantage of this elimination procedure is it can be automated and ran in batch or high-
throughput mode, without the requirement for human intervention, a feature desired of analytical tools 
for large datasets. 
 
 
 
TABLE  LEGENDS: 
 
 
Table 1.    The Training Sets.   The training structures for the determination of the 3D SMs for the 
biding sites of sialic acid, retinoic, and heme-bound and unbound nitric oxide, are shown.  The PDB 
IDs of the structures are shown on column 1, the source organism on column 2, and a brief description 
of the structures is on column 3.    
 
Table 2.    The Control Structures.   Negative control structures for SA, RA, hNO and fNO binding 
sites are shown.  As for positive control structures for those ligand binding sites, please see text.  
Positive and negative control structures used for validating the 3D SM’s for GTP-binding SRGP and 
ATP-binding STPK protein families are taken up in detail in our previous work (Reyes, V.M., 2015a). 
 
Table 3.   The  801 Functionally Unnanotated Proteins in the PDB Used As Application 
Structures.    These 801 structures were obtained from the PDB in early 2006 by querying the PDB 
search site with the words “unknown function” or similar phrase.  The absence of functional annotation 
in all 801 structures was further confirmed by examining the header information in each PDB file, 
which contained the phrase “function unknown” or a similar one in each case.   
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Table 4.  Species Distribution of Application Set.  The species distribution of the 801 application 
structures is shown in this table. The 801 structures come from 104 known species (that include 
bacteria, archaea, protozoans, and some higher organisms including humans), an uncultured bacterium 
(unknown species), and one is a synthetic protein.  The 5 most represented species are E. coli (11.0%),  
T. maritima (7.9%), T. thermophilus (7.0%), B. subtilis (6.0%) and P. aeruginosa (4.7%).   
 
Table 5, Parts 1-7.  Cutting Plane and Tangent Sphere Indices Used to Assess LBS Burial in 
Screening Results:   GTP in Small Ras-type GP (part 1 of 7);  ATP in ser/thr PK; (part 2 of 7);  
Sialic Acid (part 3 of 7);  Retinoic Acid (part 4 of 7);  Heme-Bound NO (part 5 of 7);  Unbound 
NO (part 6 of 7).   The information in the above six tables is illustrated and identified schematically in 
part 7 of 7 of the table. Results of the determination of the particular binding site burial using the 
“cutting plane” and tangent sphere” methods are shown (headings “CPM” and “TSM”, respectively).  
The degree of burial is expressed as % of protein atoms on the exterior side of the cutting plane and 
inside the tangent sphere, respectively.  Part 7 of 7 diagrammatically identifies what information are 
contained in  the tables above based on their location in the table. 
 
Table 6.   Application Structures that Tested Positive.    The structures from the set of 801 
functionally unannotated proteins (Table 3) in the PDB that tested positive of the 3D SMs of GTP (in 
small, Ras-type G-proteins, ATP (in ser/thr protein kinases), sialic acid, retinoic acid, and heme-bound 
and unbound nitric oxide are summarized in this table.   Note that most of the structures are still 
functionally unannotated at the time of this writing, as shown by the scarcity of entries in the last 
column, which is the published reference papers for the particular structure (see also References 
section).     
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